PBD Biotech, a Thurston, UK-based agtech startup, raised £400k in funding.
Backers included New Anglia Capital, regional investment groups and individual angel investors including farmers and vets.
The company intends to use the capital to fund international trials and launch a suite of products.
Set up just over 12 months ago, PBD Biotech has developed Actiphage, a sensitive test for bovine TB, Johne’s and other mycobacterial diseases in livestock, wildlife and exotics.
Actiphage can identify the presence of live bacteria in blood, milk or other tissue in as little as six hours and can also distinguish between infected and vaccinated animals. It has the UK Government’s approval for chronic herd breakdowns, and the company is currently conducting a number of field-based trials.